Thursday, 16 August 2018

Dr Reddy's gets EIR from USFDA for Mexico plant

11 April 2018 | News

Audit of its active pharmaceutical ingredient (API) Cuernavaca plant in Mexico by the USFDA was completed with zero observations

Reddy's Laboratories has received establishment inspection report (EIR) from the US health regulator for its Cuernavaca facility in Mexico.

The company had earlier said in a regulatory filing that audit of its active pharmaceutical ingredient (API) Cuernavaca plant in Mexico by the United States Food and Drug Administration (USFDA) was completed with zero observations.

As per the USFDA, after the completion of an inspection of a facility, an EIR is issued to a company detailing inspectional findings.

Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account





Survey Box

Will government's drug price caps trigger showdown with US?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls